Storebrand USA A vs UBS Lux Equity Fund Biotech USD

Storebrand USA A vs UBS Lux Equity Fund Biotech USD

1. Storebrand USA A

  • Security

    Storebrand USA A EUR

  • Fee

    0.20%

  • ISIN

    SE0013801396

  • Holdings

    25

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 35 holdings in Storebrand USA A, where the largest holding is Apple (6.63), followed by Microsoft (5.82) and Nvidia (5.55). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Storebrand USA A and UBS Lux Equity Fund Biotech USD.

Storebrand USA A UBS Lux Equity Fund Biotech USD
1. Apple Inc
USA
6.63 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Microsoft Corp
USA
5.82 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. Nvidia Corp
USA
5.55 %
3. Moderna Inc
9.21 %
4. Amazon.com Inc
USA
3.66 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. Meta Platforms A
USA
2.55 %
5. AbbVie Inc
USA
5.53 %
6. Alphabet Inc Class A
USA
1.94 %
6. Gilead Sciences Inc
USA
4.66 %
7. Broadcom Inc
USA
1.85 %
7. Amgen Inc
4.3 %
8. Tesla Inc
USA
1.73 %
8. BioNTech SE
4.13 %
9. JP Morgan Chase & Co
USA
1.66 %
9. Karuna Therapeutics Inc
3.75 %
10. Alphabet Inc Class C
USA
1.65 %
10. Royalty Pharma Plc
3.37 %
11. Eli Lilly and Co
USA
1.65 %
-
12. Visa Inc
USA
1.38 %
-
13. Netflix Inc
USA
1.05 %
-
14. Coca-Cola Company
USA
0.95 %
-
15. Mastercard Inc
USA
0.95 %
-
16. Procter & Gamble Co
USA
0.93 %
-
17. UnitedHealth Group Inc
USA
0.84 %
-
18. AbbVie Inc
USA
0.79 %
-
19. Linde Plc
Ireland
0.77 %
-
20. Abbott Laboratories
USA
0.73 %
-
21. Cisco Systems Inc
USA
0.71 %
-
22. Bank of America Corp
USA
0.7 %
-
23. Home Depot Inc
USA
0.68 %
-
24. AT&T Inc
USA
0.65 %
-
25. Salesforce.com Inc
USA
0.65 %
-

The list of fund holdings was last updated on June 5, 2025.